|
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability
|
06 February 2014 |
|
Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells
|
06 February 2014 |
|
Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3
|
06 February 2014 |
|
The novel vitamin D analog ZK191784 inhibits prostate cancer cell invasion
|
05 February 2014 |
|
Inecalcitol, an analog of 1α,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells
|
05 February 2014 |
|
Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer
|
05 February 2014 |
|
Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer
|
03 February 2014 |
|
Management of androgen-ablation refractory prostate cancer. Role for somatostatin analogues?
|
03 February 2014 |
|
Differential effects of exogenous and autocrine growth hormone on LNCaP prostate cancer cell proliferation and survival
|
02 February 2014 |
|
The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice
|
02 February 2014 |